≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart C3_SECONDARY_NAS_EXALLC for full statistics.

Secondary malignant neoplasm of other and unspecified sites

DOID Endpoint Browser

C3_SECONDARY_NAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C79
  • Cause of death: ICD-8 — 198
  • Cancer registry: Topography ICD-O-3 — C79
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

443

4. Check minimum number of events

None

443

5. Include endpoints

None

443

6. Filter based on genotype QC (FinnGen only)

443

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 443 190 253
Unadjusted period prevalence (%) 0.09 0.06 0.11
Median age at first event (years) 72.44 70.07 74.23

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
324
Matched controls
3237
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
85.3
162.1
177
45
H02AB02
ATC
dexamethasone; systemic
30.1
142.2
214
196
WF049
NOMESCO Finland
Radiotherapy of metastasis
50.9
119.4
144
50
N02AA05
ATC
oxycodone; systemic
16.8
108.6
217
349
A03FA01
ATC
metoclopramide; systemic, rectal
16.2
108.1
228
413
Z51.5
ICD-10 Finland
Palliative care
25.2
107.1
161
122
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
105.0
95
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
74.3
104.1
116
24
130
Kela drug reimbursment
Malignant tumour
18.4
99.3
173
190
JN4BD
NOMESCO Finland
Extensive body CT
16.7
98.5
182
230
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
79.8
71.5
79
13
A04AA02
ATC
granisetron; systemic, transdermal
17.2
71.1
120
107
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
7.4
60.4
215
683
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
19.3
59.6
94
67
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
19.1
55.7
88
62
XX3DW
NOMESCO Finland
Time consuming IT work
9.2
52.2
124
205
M05BX04
ATC
denosumab; parenteral
14.1
50.0
90
86
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.5
42.5
77
73
JN4CD
NOMESCO Finland
Very extensive body CT
11.1
35.7
71
80
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
24.4
35.2
50
24
A04AA01
ATC
ondansetron; systemic, rectal
10.5
35.1
72
86
WF004
NOMESCO Finland
Palliative radiotherapy
25.9
32.4
45
20
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
8.7
29.5
67
94
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
29.5
222
1153
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
24.5
29.1
41
19
L01BC06
ATC
capecitabine; oral
11.8
29.1
55
55
NK6AN
NOMESCO Finland
Total body bone isotope imaging
11.6
25.8
49
49
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
45.3
24.0
29
7
WZC30
NOMESCO Finland
Teaching
4.5
22.8
93
268
WW500
NOMESCO Finland
Blood transfusion
8.8
22.3
49
64
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
22.0
22.2
32
16
AA1BD
NOMESCO Finland
Extensive CT of head and brain
11.6
21.8
41
40
A04AD12
ATC
aprepitant; systemic
15.5
21.4
35
25
163
Kela drug reimbursment
Abiraterone and enzalutamide
23.5
21.2
30
14
L02BA03
ATC
fulvestrant; parenteral
117.6
20.8
22
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
20.3
83
237
A02BC02
ATC
pantoprazole; systemic
3.3
20.0
252
1664
192
Kela drug reimbursment
Fulvestrant
111.9
19.8
21
*
115
Kela drug reimbursment
Breast cancer
6.3
19.0
53
98
L03AA13
ATC
pegfilgrastim; parenteral
8.9
19.0
41
52
L02BB04
ATC
enzalutamide; oral
25.5
19.0
26
11
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.5
18.6
72
194
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
17.9
18.2
28
17
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.0
18.2
62
146
L02BG04
ATC
letrozole; oral
7.5
17.5
42
63
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
67.0
16.9
19
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
8.9
16.8
36
45
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
19.2
16.7
25
14
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
16.7
147
736
ZX080
NOMESCO Finland
Image guided radiotherapy
12.1
16.6
30
27
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
17.9
16.4
25
15
ZX090
NOMESCO Finland
Other technic of radiotherapy
9.1
16.2
34
41
A06AH03
ATC
naloxegol; oral
15.6
16.1
26
18
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.8
16.1
47
92
ZX070
NOMESCO Finland
Intensity modified radiotherapy
10.3
15.8
31
33
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
13.3
15.7
27
22
116
Kela drug reimbursment
Prostate cancer
4.6
15.5
57
144
L01CA04
ATC
vinorelbine; systemic
21.3
15.3
22
11
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.9
15.1
30
33
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
17.6
15.0
23
14
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
9.1
14.9
31
37
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
20.3
14.4
21
11
B01AB10
ATC
tinzaparin; parenteral
4.8
14.4
50
119
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.9
13.3
28
34
L02AE02
ATC
leuprorelin; implant, parenteral
5.0
13.2
43
96
ZX120
NOMESCO Finland
Intravenous
3.9
13.1
57
169
D70.82
ICD-10 Finland
Drug-induced neutropenia
13.0
12.8
22
18
X76
ICPC
Malignant neoplasm breast female
12.4
12.0
21
18
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
15.4
11.9
19
13
L02BA01
ATC
tamoxifen; oral
6.6
11.8
30
49
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
17.2
11.8
18
11
JN4AD
NOMESCO Finland
Body CT examination
3.7
11.8
53
161
R83
ICPC
Respiratory infection other
0.0
11.8
*
277
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
31.3
11.7
15
5
A79
ICPC
Malignancy NOS
10.6
11.7
22
22
L02BX03
ATC
abiraterone; oral
23.9
11.7
16
7
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
6.5
11.3
29
48
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
13.4
11.3
19
15
L02AE03
ATC
goserelin; implant
10.6
11.2
21
21
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.2
11.1
43
114
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
44.9
11.0
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
5.3
10.9
33
68
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.2
10.7
33
69
L02BB03
ATC
bicalutamide; oral
5.2
10.7
33
69
J01MA12
ATC
levofloxacin; systemic
2.5
10.7
96
461
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
113.5
10.5
11
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
113.5
10.5
11
*
B01AB05
ATC
enoxaparin; parenteral
2.3
10.4
130
738
HA1AA
NOMESCO Finland
X-ray mammography
4.4
10.2
37
92
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
10.2
66
261
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
12.7
10.0
17
14
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.0
9.9
19
20
L17
ICPC
Foot/toe symptom/complaint
0.3
9.9
17
577
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
27.0
9.9
13
5
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
56.7
9.7
11
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
5.5
9.6
28
55
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
9.6
83
386
N02BE01
ATC
paracetamol; systemic, rectal
2.9
9.5
290
2425
R50.9
ICD-10 Finland
Fever, unspecified
2.8
9.5
67
277
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
9.5
54
196
HAC20
NOMESCO Finland
Total mastectomy
6.1
9.4
25
44
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.6
9.3
32
76
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
9.1
46
153
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
9.1
109
599
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
37.8
9.1
11
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
5.4
9.0
26
51
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.7
8.9
22
35
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
8.9
80
381
Y77
ICPC
Malignant neoplasm prostate
4.8
8.6
28
63
1501
Kela drug reimbursment
Palbociclib
28.4
8.5
11
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
28.4
8.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
6.1
8.5
22
38
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.0
8.4
*
203
NF3AA
NOMESCO Finland
Femur X-ray examination
6.8
8.3
20
31
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.9
8.3
18
24
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
15.0
8.3
13
9
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.0
8.2
48
177
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
8.2
35
102
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
34.3
8.1
10
*
L02BX02
ATC
degarelix; parenteral
10.4
8.1
15
15
N02AX02
ATC
tramadol; systemic, rectal
2.0
8.1
158
1052
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.6
8.0
61
263
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
7.9
55
225
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
11.2
7.9
14
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
7.7
74
361
N03AX14
ATC
levetiracetam; systemic
6.4
7.7
19
31
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
12.2
7.6
13
11
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
9.2
7.6
15
17
L01XE33
ATC
[U] palbociclib; oral
25.7
7.6
10
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
25.7
7.6
10
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
25.7
7.6
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
4.0
7.6
29
77
N03AX16
ATC
pregabalin; oral
2.2
7.5
92
501
SPAT1254
SPAT
Administration of medicine
2.4
7.4
70
339
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
11.2
7.4
13
12
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
7.3
7
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
30.7
7.2
9
*
A06AD11
ATC
lactulose; oral
2.3
7.1
71
354
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
10.4
7.1
13
13
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.4
7.1
61
281
C50.99
ICD-10 Finland
Breast, unspecified
6.6
7.0
17
27
ZX112
NOMESCO Finland
Subcutaneous
6.1
7.0
18
31
TGD00
NOMESCO Finland
Needle biopsy of lung
14.2
6.9
11
8
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
14.2
6.9
11
8
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.1
6.9
*
223
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.5
6.9
19
36
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
11.3
6.8
12
11
L03AA02
ATC
filgrastim; parenteral
5.1
6.8
20
41
180
Kela drug reimbursment
Interferon alfa
40.9
6.8
8
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.6
6.7
29
86
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
23.1
6.7
9
*
L01CB01
ATC
etoposide; systemic
12.6
6.6
11
9
L02BG06
ATC
exemestane; oral
9.0
6.6
13
15
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
10.3
6.6
12
12
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
10.3
6.6
12
12
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
6.4
104
629
JN4DD
NOMESCO Finland
Scout CT scan of torso
71.2
6.4
7
*
L01XE23
ATC
[U] dabrafenib; oral
71.2
6.4
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
8.4
6.4
13
16
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.3
6.4
30
96
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
11.3
6.3
11
10
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
18.4
6.3
9
5
159
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
27.2
6.3
8
*
J94.8
ICD-10 Finland
Other specified pleural conditions
6.0
6.2
16
28
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
6.1
81
453
WW200
SPAT
NA
0.0
6.1
*
153
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.8
6.1
10
8
WF099
NOMESCO Finland
Other radiotherapy
12.8
6.1
10
8
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.1
6.1
*
179
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
10.3
6.1
11
11
AA1AD
NOMESCO Finland
CT of head and brain
2.0
6.0
95
568

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
165
473
4.97
55.04
4.9
4.5
ug/l
114.7
29.2
1.26
153
405
(3023368) Bacteria identified in Blood by Culture
262
1191
3.94
44.40
5.3
4.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
352
2014
4.64
41.40
14.9
6.8
umol/l
10.3
11.8
1.19
346
1905
(4035726)
123
352
4.45
39.78
1.5
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
168
650
3.55
34.68
5.0
3.4
mmol/l
0.8
0.8
0.49
162
611
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
330
1951
3.71
33.49
10.2
7.1
mmol/l
1.2
1.2
0.23
231
1645
(3013650) Neutrophils [#/volume] in Blood by Automated count
343
2106
3.79
32.17
17.4
9.2
e9/l
4.8
4.1
3.38
329
1851
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
305
1791
3.26
29.73
8.1
6.2
mmol/l
1.2
1.2
0.43
293
1602
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
56
7.75
27.58
4.5
2.9
%
64.9
58.6
1.42
40
56
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
233
3384
0.34
26.74
4.6
6.5
mmol/mol
43.9
40.8
0.85
193
3109
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
248
3476
0.35
25.39
2.9
4.7
mmol/l
1.4
1.5
0.60
203
3156
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
263
3586
0.34
25.38
3.0
5.4
mmol/l
2.7
2.6
0.47
211
3255
(3032080) INR in Blood by Coagulation assay
286
1708
2.90
25.35
7.7
10.4
inr
1.2
1.3
2.77
96
474
(3030905) Polymorphonuclear cells [#/volume] in Blood
37
53
7.53
24.97
4.0
2.3
e9/l
4.3
4.9
0.53
37
53
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
254
3503
0.36
24.25
2.9
4.8
mmol/l
4.5
4.5
0.32
209
3206
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
66
1767
0.26
24.15
1.9
2.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
45
88
5.58
22.43
4.6
4.5
mmol/l
3.3
2.5
0.67
32
56
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
64
6.03
19.78
1.2
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
106
422
2.99
19.52
6.3
3.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
91
4.99
18.62
1.2
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
208
1184
2.43
18.37
6.2
4.4
ph
7.4
7.4
0.55
90
236
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
250
3358
0.41
17.90
2.8
4.2
mmol/l
1.3
1.3
0.96
205
3026
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40
90
4.79
16.95
1.2
1.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
208
1224
2.32
16.56
2.9
2.5
u/l
50.7
57.0
1.22
199
1131
(3013826) Glucose [Moles/volume] in Serum or Plasma
321
2281
2.48
16.30
6.1
5.0
mmol/l
6.8
6.8
0.10
308
2150
(3024561) Albumin [Mass/volume] in Serum or Plasma
265
1737
2.31
16.19
5.2
4.9
g/l
30.1
34.9
24.68
255
1609
(3015377) Calcium [Moles/volume] in Serum or Plasma
220
1336
2.28
16.14
6.3
3.5
mmol/l
2.3
2.4
3.05
202
1158
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
374
2871
2.94
15.96
17.5
8.1
u/l
123.4
79.5
11.66
360
2679
(3004809) Band form neutrophils/100 leukocytes in Blood
33
67
5.24
15.72
1.5
3.6
%
3.1
1.5
0.79
26
55
(40761536) Microorganisms panel - Urine sediment
82
318
2.94
15.60
3.5
3.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
30
59
5.38
14.79
5.0
3.3
u/ml
140.9
35.8
1.58
30
59
(42870588) Differential panel, method unspecified - Blood
202
1222
2.20
14.53
4.1
5.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
31
65
5.05
14.23
1.4
3.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
243
1598
2.15
13.94
3.9
4.1
ng/l
49.0
67.7
0.29
215
1217
(3044640) Blood type and Crossmatch panel - Blood
199
1215
2.16
13.80
2.9
2.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
97
4.19
13.73
1.2
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
33
1029
0.27
13.56
1.3
1.6
nmol/l
15.6
20.6
1.57
27
865
(1616796) Gas panel - Central venous blood
34
84
4.30
12.81
4.0
3.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
26
53
5.15
12.31
1.2
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
28
62
4.75
12.06
1.0
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
326
2483
2.18
11.82
5.0
4.7
e6/l
89.3
3995.7
—
9
47
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
288
3516
0.48
11.29
3.7
5.0
mmol/l
6.0
6.1
0.21
240
3176
(3019225) pH of Specimen
82
375
2.46
11.07
7.6
4.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
46
156
3.17
10.93
2.1
3.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
135
764
2.10
10.92
3.8
4.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
248
1753
1.94
10.51
5.3
4.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
30
6.21
10.47
1.2
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
243
1714
1.93
10.29
4.8
6.0
%
19.1
26.7
21.37
228
1591
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
98
1659
0.47
9.68
1.7
2.1
pmol/l
78.8
93.5
3.28
60
858
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
35
108
3.43
9.66
1.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
40
5.19
9.66
1.2
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
238
1690
1.88
9.64
4.6
6.0
%
8.5
8.9
0.96
223
1576
(3029937) Albumin [Presence] in Urine by Test strip
161
1007
1.94
9.64
4.4
4.2
estimate
0.0
0.0
0.50
63
323
(3006504) Eosinophils/100 leukocytes in Blood
235
1681
1.85
9.12
4.3
5.7
%
1.9
2.9
9.59
219
1560
(3020682) Albumin/Creatinine [Ratio] in Urine
69
1301
0.44
8.98
3.0
3.9
mg/mmol
10.1
9.7
0.04
41
822
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
43
4.82
8.91
1.2
2.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
64
1234
0.44
8.79
1.9
3.1
mmol/l
6.3
7.4
1.51
44
1010
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
265
3241
0.55
8.45
3.9
4.6
mu/l
2.0
2.4
0.54
228
2888
(40768806) Pleura Pathology biopsy report
23
58
4.13
8.44
1.4
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
19
41
4.80
8.43
1.2
2.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
65
1224
0.45
8.28
2.0
3.2
mg/l
865.0
269.4
0.34
34
797
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
23
59
4.06
8.25
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
17
34
5.16
8.20
1.2
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
17
34
5.16
8.20
1.2
2.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
17
34
5.16
8.20
1.2
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
16
31
5.32
7.98
1.3
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
22
56
4.08
7.98
2.1
2.1
%
90.6
89.5
0.58
22
56
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
61
282
2.35
7.95
1.6
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
225
1640
1.76
7.75
4.4
5.7
%
0.5
0.7
5.88
212
1525
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
50
4.14
7.42
1.3
1.3
e6/l
16481.5
32997.7
0.64
15
29
(3042936) Bacteria identified in Isolate by Culture
103
605
1.92
7.16
1.4
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
66
3.62
7.08
1.1
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
58
1087
0.46
7.08
2.2
3.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
20
6.14
6.94
1.3
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
20
6.14
6.94
1.2
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
66
334
2.15
6.91
2.1
4.2
%
1.7
0.8
2.23
48
119
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
40
162
2.61
6.90
2.0
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
17
6.61
6.80
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
32
116
2.90
6.79
1.2
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
399
3529
2.32
6.74
28.5
16.7
mg/l
42.7
26.3
13.77
377
2852
(3019198) Lymphocytes [#/volume] in Blood
240
1828
1.68
6.68
4.6
5.7
e9/l
1.4
2.0
8.14
222
1622
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
18
6.24
6.46
1.3
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
150
2.60
6.37
2.2
2.4
u/ml
0.4
0.3
0.52
28
81
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
73
3.27
6.10
1.1
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
0
152
0.00
6.08
0.0
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
108
676
1.79
6.05
1.8
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
191
1397
1.65
6.03
4.8
4.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
13
27
4.93
6.01
1.7
3.8
—
—
—
0
0
(3026782) Osmolality of Urine
125
821
1.73
5.91
2.8
3.0
mosm/kgh2o
513.8
559.6
2.01
114
700
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
20
5.61
5.83
1.3
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
20
5.61
5.83
1.3
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
20
5.61
5.83
1.3
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
20
5.61
5.83
1.3
2.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
32
706
0.41
5.82
3.6
2.9
e6/l
0.8
1.0
0.24
22
420
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
17
6.00
5.65
1.3
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
17
6.00
5.65
1.3
2.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
220
1687
1.60
5.61
4.3
5.8
%
65.6
57.7
15.66
207
1578
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
136
0.00
5.54
0.0
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
29
4.59
5.54
1.2
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
238
1863
1.60
5.54
4.2
5.7
e9/l
0.2
0.2
2.39
217
1640
(3021440) Promyelocytes/100 leukocytes in Blood
59
311
2.03
5.54
2.1
4.3
%
0.2
0.1
0.47
44
109
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
52
3.57
5.51
1.8
3.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
100
1485
0.58
5.45
1.6
2.2
nmol/l
80.0
78.1
0.25
92
1294
(3037467) Urinalysis macro (dipstick) panel - Urine
305
2543
1.64
5.39
4.7
4.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
231
1804
1.59
5.37
4.2
5.5
e9/l
0.0
0.0
2.70
213
1560
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
32
684
0.43
5.35
1.1
1.2
u/ml
1.0
1.1
0.17
12
184
(3023183) Ammonium ion [Moles/volume] in Plasma
26
97
2.79
5.27
1.7
3.3
umol/l
46.4
32.9
0.70
17
79
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
59
3.32
5.23
1.2
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
529
0.37
5.14
1.1
1.3
u/ml
25.3
12.8
—
6
194
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
34
150
2.37
4.94
1.9
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
545
0.39
4.90
1.0
1.3
iu/ml
50.5
42.9
—
7
161
(3020891) Body temperature
36
165
2.29
4.80
3.6
4.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
8
7
11.61
4.80
1.6
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
227
1797
1.54
4.76
4.2
5.5
e9/l
0.7
0.6
1.71
212
1544
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
215
2623
0.65
4.76
3.8
3.7
pmol/l
15.2
15.0
0.67
185
2330
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
118
0.00
4.60
0.0
1.1
—
—
—
0
0
(3013512) EKG study
162
1212
1.53
4.29
3.7
4.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
9
9.03
4.29
1.5
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
36
3.69
4.23
1.4
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
121
853
1.58
4.16
2.4
2.6
e6/l
8.9
4.3
2.39
112
756
(3019060) Gas panel - Arterial blood
53
299
1.88
4.10
4.3
4.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
228
0.25
4.03
1.0
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
161
1217
1.51
4.01
3.2
3.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
36
668
0.50
4.01
3.8
3.1
e6/l
0.7
1.7
2.22
26
386
(3002385) Erythrocyte distribution width [Ratio]
247
2872
0.68
3.74
29.9
20.6
%
15.2
13.8
21.97
241
2820
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
126
921
1.51
3.63
2.6
2.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
51
3.01
3.61
1.5
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
37
194
1.99
3.56
3.0
3.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
31
3.61
3.50
1.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
34
175
2.02
3.44
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
256
0.34
3.42
1.3
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
111
800
1.52
3.39
6.8
3.2
mmol/l
2.5
2.5
1.76
100
702
(3007164) IgA [Mass/volume] in Serum or Plasma
35
621
0.53
3.37
1.2
1.4
g/l
2.9
2.7
0.16
26
358
(3014051) Protein [Presence] in Urine by Test strip
0
85
0.00
3.35
0.0
2.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
29
143
2.10
3.29
4.9
3.1
g/l
0.3
0.3
0.06
23
52
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
19
4.81
3.25
3.4
4.5
nmol/l
344.4
107.2
—
9
19
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
152
1182
1.44
3.14
2.0
2.1
u/l
162.4
295.8
1.11
140
1104
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
257
1.79
3.08
1.5
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
129
980
1.45
3.00
4.2
3.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
49
298
1.72
2.99
2.3
4.1
%
1.0
0.4
2.48
32
88
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
26
128
2.10
2.98
1.2
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
121
912
1.45
2.93
16.1
7.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
77
529
1.55
2.91
3.9
5.6
mmol/l
1.0
1.0
0.69
71
483
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
306
3372
0.70
2.90
29.1
15.6
ml/min/173m2
78.9
74.5
2.90
278
2809
(44790048)
12
41
2.98
2.88
1.0
1.7
—
—
—
0
0
(44790047)
12
41
2.98
2.88
1.0
1.7
—
—
—
0
0
(44790049)
12
41
2.98
2.88
1.0
1.7
—
—
—
0
0
(44806118)
12
41
2.98
2.88
1.0
1.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
13
5.45
2.88
1.1
4.9
%
55.9
50.0
—
7
13
(3008898) HLA-B27 [Presence]
0
75
0.00
2.78
0.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
48
2.76
2.74
1.1
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
251
1.74
2.74
3.0
3.7
mmol/l
2.6
1.9
0.49
37
189
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
19
4.27
2.69
1.5
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
164
0.30
2.61
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
50
2.65
2.55
1.1
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
50
2.65
2.55
1.1
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
50
2.65
2.55
1.1
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
13
50
2.65
2.55
1.5
1.1
u/l
22.7
12.1
1.11
13
39
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
50
2.65
2.55
1.1
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
361
0.48
2.52
1.1
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
398
3741
1.63
2.51
28.7
19.7
mmol/l
137.5
139.7
26.52
384
3643
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
8
21
3.86
2.47
1.5
1.9
—
15.8
—
0
10
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
51
2.60
2.46
1.1
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
118
1488
0.72
2.45
1.9
2.7
ug/l
656.2
151.7
4.92
105
1360
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
63
0.00
2.44
0.0
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
398
3747
1.61
2.42
28.6
19.8
mmol/l
4.0
4.0
1.89
385
3648
(3048689) Calprotectin [Mass/mass] in Stool
17
340
0.48
2.37
1.5
2.1
ug/g
143.1
145.2
0.02
17
268
(3009261) Glucose [Presence] in Urine by Test strip
212
1810
1.33
2.29
4.5
4.1
estimate
0.0
0.0
0.50
74
326
(3037522) Nuclear Ab [Titer] in Serum
24
423
0.54
2.27
1.2
1.3
titre
320.0
427.8
—
5
108
(3020630) Protein [Mass/volume] in Serum or Plasma
54
364
1.55
2.24
2.3
3.1
g/l
65.2
66.1
0.33
49
331
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
29
3.15
2.23
1.4
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
131
1607
0.74
2.23
20.0
10.3
e9/l
0.0
0.0
0.71
114
1327
(3026493) Urate [Moles/volume] in Serum or Plasma
74
993
0.69
2.17
2.8
3.0
umol/l
339.5
8624.1
4.81
65
844
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
175
1463
1.32
2.16
3.0
3.3
—
—
—
0
0
(4281824)
9
31
2.94
2.08
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
56
0.00
2.07
0.0
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
5
147
0.33
2.04
1.2
2.8
g/l
0.0
0.9
—
5
131
(3014891) Appearance of Pleural fluid
5
11
4.58
1.94
1.0
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
162
1356
1.31
1.94
2.5
3.2
ng/l
1798.2
1568.8
0.24
141
1179
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
349
0.55
1.85
1.4
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
53
373
1.48
1.82
2.3
2.7
ug/l
4.0
6.7
1.45
42
327
(40761511) CBC panel - Blood by Automated count
385
3642
1.44
1.81
28.7
16.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
49
340
1.50
1.80
3.7
3.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
23
3.08
1.80
1.3
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
43
291
1.53
1.78
2.2
4.3
%
0.3
0.1
0.36
36
92
(3021601) Nitrite [Presence] in Urine by Test strip
205
1785
1.28
1.78
5.6
5.5
estimate
0.0
0.0
0.00
71
339
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
76
980
0.73
1.74
2.8
3.3
ug/l
1.6
0.8
2.83
59
700
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
17
303
0.54
1.71
1.5
1.8
%
2.5
1.6
0.50
11
258
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
48
0.00
1.70
0.0
1.1
—
23.3
—
0
10
(3035880) pH of Pleural fluid
8
31
2.61
1.66
1.0
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
7
25
2.83
1.65
1.3
1.4
u/l
37.0
33.8
—
7
19
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
131
0.37
1.65
1.2
2.7
g/l
0.0
0.0
—
5
122
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
241
2153
1.26
1.64
3.0
3.3
u/l
108.8
51.9
2.46
220
1970
(3045788) Cell count panel - Pleural fluid
10
43
2.36
1.61
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
203
1785
1.25
1.56
4.3
4.1
estimate
0.0
0.0
0.00
72
340
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
142
0.41
1.55
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
86
1.89
1.52
1.3
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
45
0.00
1.50
0.0
1.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
65
494
1.37
1.49
5.7
7.4
kpa
5.2
5.1
0.23
60
476
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
12
227
0.52
1.48
2.0
2.5
—
12.4
—
0
6
(3013707) Erythrocyte sedimentation rate by Westergren method
247
2705
0.80
1.48
3.0
4.2
mm/h
26.9
13.8
10.43
213
2457
(3027801) Oxygen [Partial pressure] in Arterial blood
65
495
1.37
1.47
5.7
7.4
kpa
11.9
11.8
0.03
59
478
(3003396) Base excess in Arterial blood by calculation
65
495
1.37
1.47
5.7
7.5
mmol/l
2.7
1.2
1.96
44
388
(3017354) Segmented neutrophils/100 leukocytes in Blood
10
45
2.25
1.47
1.2
3.1
%
64.8
57.2
—
5
33
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
211
0.51
1.42
1.2
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
139
0.42
1.42
1.2
2.6
g/l
28.6
37.2
—
6
120
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
123
0.40
1.39
1.2
2.8
g/l
0.0
0.0
—
5
115
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
124
0.40
1.38
1.2
2.8
g/l
0.0
0.0
—
5
115
(3008295) Osmolality of Serum or Plasma
9
41
2.22
1.37
1.0
1.5
mosm/kgh2o
273.2
277.2
—
9
27
(3044889) 12 lead EKG panel
243
2655
0.81
1.37
4.4
4.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
32
458
0.68
1.34
1.2
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
134
0.44
1.30
1.3
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
35
2.31
1.27
1.0
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
61
472
1.34
1.26
1.6
1.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
11
200
0.54
1.22
1.0
1.3
—
48.4
—
0
13
(3007461) Platelets [#/volume] in Blood
399
3848
1.37
1.19
40.0
24.5
e9/l
257.1
240.7
3.38
386
3744
(3024731) MCV [Entitic volume]
399
3848
1.37
1.19
39.9
24.4
fl
92.0
91.8
0.43
386
3785
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
223
0.57
1.19
2.2
2.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
108
909
1.25
1.19
1.6
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
399
3849
1.37
1.18
40.0
24.5
e12/l
3.9
4.4
55.41
385
3729
(3010813) Leukocytes [#/volume] in Blood
399
3849
1.37
1.18
40.1
24.5
e9/l
7.6
6.8
4.79
388
3728
(3035941) MCH [Entitic mass]
399
3849
1.37
1.18
39.9
24.4
pg
30.2
30.5
1.94
387
3785
(3025577) Chromium [Mass/volume] in Blood
0
33
0.00
1.16
0.0
2.2
—
2.3
—
0
27
(4024509)
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
34
0.00
1.16
0.0
1.0
—
2.8
—
0
10
(3000963) Hemoglobin [Mass/volume] in Blood
399
3851
1.36
1.15
40.3
24.6
g/l
118.0
133.9
59.85
388
3785
(3019150) Specific gravity of Urine by Refractometry
95
791
1.26
1.15
5.0
4.5
kg/l
1.0
1.0
1.81
19
124
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
61
480
1.31
1.14
17.2
7.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
141
1229
1.22
1.11
3.0
3.4
e6/l
266.2
124.8
0.40
123
959
(40760888) Immunoglobulin light chains.free panel - Serum
16
97
1.67
1.08
1.2
5.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
123
0.48
1.06
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
64
789
0.78
1.06
2.8
4.2
ng/l
157.9
328.1
1.01
49
676
(3000492) Spirometry study
19
287
0.65
1.06
1.3
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
68
1.79
1.01
3.8
2.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
161
0.55
0.99
1.1
2.5
g/l
11.3
10.5
—
9
139
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
2.1
—
0
12
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
31
0.00
0.96
0.0
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
31
0.00
0.96
0.0
2.0
—
10.3
—
0
31
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
4.5
—
21.5
—
0
8
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.2
—
94.4
—
0
5
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
116
0.51
0.95
1.2
1.2
—
2.6
—
0
7
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
32
0.00
0.95
0.0
1.0
—
298.7
—
0
18
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
32
0.00
0.95
0.0
1.0
—
485.9
—
0
19
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
32
0.00
0.95
0.0
1.0
—
44.1
—
0
17
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
119
0.50
0.95
1.2
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
287
3037
0.84
0.93
20.8
18.1
%
33.1
38.9
6.22
124
1935
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
28
2.16
0.92
1.5
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
28
2.16
0.92
1.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
28
2.16
0.92
1.5
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
33
435
0.74
0.90
1.2
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
387
3745
1.26
0.88
18.8
11.3
u/l
27.4
24.9
1.20
373
3592
(40768804) Tissue Pathology biopsy report
162
1459
1.17
0.87
2.3
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
120
1355
0.84
0.85
5.0
4.8
%
26.2
21.0
2.59
75
718
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
176
0.62
0.81
1.2
2.4
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.1
—
1.0
—
0
11
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.1
—
2.2
—
0
10
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
26
0.00
0.78
0.0
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
94
815
1.19
0.78
2.1
1.7
nmol/l
1359.0
1208.5
0.79
78
616
(3000991) Gas panel - Venous blood
26
347
0.73
0.78
7.6
8.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
0
28
0.00
0.76
0.0
5.0
—
7.4
—
0
9
(40768793) Breast Pathology biopsy report
12
75
1.62
0.75
1.5
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
57
472
1.24
0.75
1.5
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
219
0.67
0.75
4.7
4.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
386
3748
1.23
0.75
34.4
20.1
umol/l
79.2
83.0
1.48
386
3748
(3034860) Kappa light chains.free [Mass/volume] in Serum
19
133
1.45
0.75
1.2
4.7
mg/l
46.4
115.8
0.73
12
103
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
19
133
1.45
0.75
1.2
4.7
mg/l
38.6
35.1
0.07
12
106
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
67
787
0.82
0.74
1.5
1.7
mg/l
2.2
1.4
0.79
49
623
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
117
0.59
0.69
1.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
167
0.65
0.67
1.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
155
1688
0.87
0.67
7.0
5.7
ug/l
20.9
2.9
5.31
144
1493
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
28
1.79
0.66
2.8
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
11
70
1.59
0.65
1.0
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
95
1.49
0.65
1.5
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
101
0.59
0.63
1.7
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
73
836
0.85
0.62
5.3
4.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
51
1.58
0.60
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
20
0.00
0.60
0.0
1.1
—
134.8
—
0
20
(3028707) Methadone [Presence] in Urine by Screen method
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(44813793)
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(4027681)
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
5.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.2
—
43.3
—
0
7
(40768800) Prostate Pathology biopsy report
7
116
0.60
0.58
1.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
58
499
1.19
0.55
1.7
2.6
%
2.1
1.8
0.88
51
455
(3027273) Bicarbonate [Moles/volume] in Venous blood
28
223
1.27
0.54
3.5
3.4
mmol/l
25.6
24.9
0.31
28
216
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
64
1.41
0.51
1.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
36
299
1.22
0.49
1.4
2.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
108
0.64
0.49
1.1
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
116
1062
1.13
0.48
3.1
3.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
82
0.61
0.46
3.0
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
83
0.60
0.46
1.0
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
122
1126
1.12
0.45
2.9
3.3
e6/l
0.9
0.6
0.77
108
860
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
51
1.38
0.44
2.4
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
13
172
0.75
0.41
1.2
1.2
iu/ml
52.9
139.1
—
6
61
(3043410) Blood group antigens tested for on Red Blood Cells
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
16
0.00
0.41
0.0
1.6
—
62.8
—
0
16
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
32
378
0.83
0.41
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
132
1.30
0.41
3.2
5.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
17
0.00
0.40
0.0
1.1
—
7.5
—
0
17
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
17
0.00
0.40
0.0
3.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
149
1398
1.10
0.40
3.2
4.0
e6/l
169.0
101.8
0.56
126
1034
(3011288) Drugs identified in Urine by Screen method
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
135
0.73
0.36
1.2
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
6
41
1.47
0.36
6.0
2.3
—
3.8
—
0
9
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
48
426
1.14
0.34
2.4
3.1
umol/l
9.8
9.1
0.08
42
383
(40768795) Lymph node Pathology biopsy report
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
32
370
0.85
0.33
5.4
6.7
mmol/l
1.7
1.4
0.53
32
355
(3007853) Bacteria identified in Skin by Aerobe culture
50
447
1.13
0.32
1.9
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
7
97
0.72
0.31
2.4
3.0
nmol/l
0.7
0.9
—
7
73
(3004119) Hemoglobin [Mass/volume] in Venous blood
24
282
0.84
0.30
3.5
3.2
g/l
117.9
125.7
1.04
24
276
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
45
503
0.88
0.30
2.3
4.8
%
33.4
31.8
0.40
32
336
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
93
1.30
0.30
2.3
4.5
mg/l
26.0
30.0
—
5
61
(3017446) Testosterone [Moles/volume] in Serum or Plasma
31
269
1.16
0.30
2.1
2.3
nmol/l
3.7
12.4
6.30
26
234
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
16
194
0.82
0.28
2.4
3.9
mmol/l
24.1
24.3
0.04
16
174
(4034850)
9
117
0.76
0.27
6.8
10.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
64
1.25
0.27
1.1
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
54
592
0.90
0.27
20.3
26.3
inr
1.2
1.3
—
8
76
(3052851) Hemolysis interference index of Serum or Plasma
14
114
1.24
0.25
6.0
3.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
44
398
1.12
0.25
3.1
3.7
mmol/l
3.8
2.0
1.44
32
319
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
1.8
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
42
1.19
0.21
1.4
3.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
11
0.00
0.21
0.0
1.1
—
3.9
—
0
11
(3016244) Insulin [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.7
—
12.4
—
0
11
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
12.1
—
786.9
—
0
10
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
15.0
—
1141.8
—
0
10
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
6.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
10
0.00
0.21
0.0
1.2
—
22.6
—
0
10
(3042733) HLA Ab [Presence] in Serum
0
12
0.00
0.21
0.0
5.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
43
1.16
0.21
1.8
2.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
43
1.16
0.21
4.6
4.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
9.7
—
0
13
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
193
1.15
0.20
2.7
3.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
12
143
0.83
0.19
1.2
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
34
309
1.11
0.19
1.2
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
58
1.21
0.18
2.4
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
61
1.15
0.17
1.0
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
36
330
1.10
0.17
1.2
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
309
0.90
0.17
2.5
3.1
ml/min/173m2
61.2
60.2
—
8
129
(3022621) pH of Urine by Test strip
23
257
0.89
0.17
4.7
3.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
76
0.79
0.15
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
76
0.79
0.15
1.5
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14
121
1.16
0.15
1.4
1.6
—
111.4
—
0
7
(3021447) Carbon dioxide [Partial pressure] in Venous blood
43
401
1.08
0.15
3.1
3.7
kpa
5.8
5.7
0.18
43
387
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
7
89
0.78
0.14
1.6
2.6
%
286.9
201.1
—
7
84
(3002256) Pathology report gross observation
49
461
1.07
0.14
1.2
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
100
0.80
0.13
1.4
2.8
mg/l
1.4
1.7
—
8
90
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
199
1.11
0.13
1.0
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
51
538
0.94
0.12
6.4
6.8
mmol/l
102.3
104.2
1.72
51
523
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
85
1.18
0.12
1.2
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
49
516
0.94
0.11
1.2
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
20
216
0.92
0.08
3.0
2.5
%
0.8
0.7
1.26
20
211
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
91
885
1.04
0.08
1.5
1.8
pmol/l
426.1
5502495.7
0.50
75
727
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
64
0.78
0.08
1.0
1.8
pg
28.0
32.8
—
5
64
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
72
0.83
0.07
2.3
2.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
6
74
0.81
0.07
1.0
1.2
e6/l
1.3
12.5
—
6
61
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
6
74
0.81
0.07
1.3
1.3
e6/l
28.5
1573.0
—
6
62
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
85
1.06
0.07
2.2
1.2
mg/l
482.2
512.9
—
9
79
(42529406) Shigella sp [Presence] in Stool by Culture
9
100
0.90
0.06
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
21
222
0.94
0.05
11.9
10.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
33
342
0.96
0.04
3.6
2.9
kpa
4.4
4.3
0.20
33
328
(3023520) Reticulocytes [#/volume] in Blood
39
380
1.03
0.03
2.1
2.7
e9/l
73.3
70.4
0.21
32
307
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
104
1028
1.02
0.02
1.5
2.1
mg/l
4.3
3.2
1.87
94
891
(46235355) HIV 1 and 2 tests - Meaningful Use set
36
369
0.97
0.02
1.1
1.6
—
—
—
0
0
(4010399)
28
288
0.97
0.02
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.7
—
0
5
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
112.0
—
0
5
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
20.9
—
0
8
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
99
0.91
0.00
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
52
0.96
0.00
1.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
3.1
—
135.5
—
0
8
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
99
0.91
0.00
1.1
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
1377.6
—
0
7
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
7
70
1.00
0.00
1.0
1.4
—
8.6
—
0
18
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
6.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
8
0.00
0.00
0.0
6.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4094501)
8
83
0.96
0.00
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
79
0.88
0.00
1.4
1.7
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
81.3
—
0
7
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
81.0
—
0
6
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
66
0.91
0.00
2.5
2.7
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_SECONDARY_NAS – Secondary malignant neoplasm of other and unspecified sites

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).